![Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-2045-6/MediaObjects/12967_2019_2045_Fig8_HTML.png)
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text
![Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-2045-6/MediaObjects/12967_2019_2045_Fig5_HTML.png)
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text
Differential Impact of Statin on New-Onset Diabetes in Different Age Groups: A Population-Based Case-Control Study in Women from an Asian Country | PLOS ONE
![PDF) Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: Results from the LIPID trial PDF) Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: Results from the LIPID trial](https://www.researchgate.net/profile/Andrew-Tonkin-3/publication/45192908/figure/fig2/AS:669980395831302@1536747182338/Kaplan-Meier-plots-showing-the-effects-of-pravastatin-on-CHD-events-CHD-death-or_Q320.jpg)
PDF) Secondary Prevention of Cardiovascular Events With Long-Term Pravastatin in Patients With Diabetes or Impaired Fasting Glucose: Results from the LIPID trial
![PDF) Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients PDF) Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients](https://i1.rgstatic.net/publication/235897268_Comparison_of_Efficacy_and_Safety_of_Rosuvastatin_Atorvastatin_and_Pravastatin_among_Dyslipidemic_Diabetic_Patients/links/618d2d0407be5f31b7682860/largepreview.png)
PDF) Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
![Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-019-2045-6/MediaObjects/12967_2019_2045_Fig2_HTML.png)